Guidance on paclitaxel for ovarian cancer updated by UK NICE Media release 10 February 2013 Pages: 4 - 4
Hepatitis vaccination guidelines for prisons released by the US CDC Guideline 10 February 2013 Pages: 5 - 5
Should the surge in DTC advertising mean greater liability for pharma? Comment 10 February 2013 Pages: 5 - 5
Pill scare sees third-generation OC use drop “dramatically” Clinical study 10 February 2013 Pages: 6 - 6
RSV infection prophylaxis not worth it in US paediatrics Clinical study 10 February 2013 Pages: 6 - 6
Cardiovascular risk scores improve prescribing in diabetes mellitus Clinical study 10 February 2013 Pages: 7 - 7
Preventing opportunistic infections in HIV worth it in France? Clinical study 10 February 2013 Pages: 7 - 7
Intravascular ultrasound “very cost-effective” option for PCI Clinical study 10 February 2013 Pages: 8 - 8
Psychiatric resource use differs between US ethnic groups Clinical study 10 February 2013 Pages: 8 - 8
Dimethyl sulfoxide preferred in reflex sympathetic dystrophy Clinical study 10 February 2013 Pages: 12 - 12
Drug compliance in the US falls as patient copayments rise Clinical study 10 February 2013 Pages: 12 - 12
Eptifibatide better value than abciximab in coronary disorders Clinical study 10 February 2013 Pages: 13 - 13
Genotype-directed therapy worth it in azathioprine-treated patients Clinical study 10 February 2013 Pages: 13 - 13
GP prescribing of new drugs influenced by pharma representatives Clinical study 10 February 2013 Pages: 13 - 13
Zidovudine therapy in HIV infections shows ethnic variation in use Clinical study 10 February 2013 Pages: 13 - 13
Fluorouracil plus eniluracil maintains QOL in colorectal cancer Clinical study 10 February 2013 Pages: 14 - 14
Serum testosterone to trigger re-dosing of goserelin improves QOL Clinical study 10 February 2013 Pages: 14 - 14
US spending on DTC advertising led by AstraZeneca's esomeprazole News item 10 February 2013 Pages: 16 - 16